Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yewei Fang, Shuan Tao, Huimin Chen, Yao Xu, Luyan Chen & Wei Liang. (2024) ESBL-Producing and Non-ESBL-Producing Escherichia coli Isolates from Urinary Tract Differ in Clonal Distribution, Virulence Gene Content and Phylogenetic Group. Infection and Drug Resistance 16, pages 5563-5571.
Read now
Read now
Mulu Gebretsadik Gebremedhin, Yemane Weldu, Atsebaha Gebrekidan Kahsay, Gebrecherkos Teame & Kelemework Adane. (2024) Extended-Spectrum β-Lactamase and Carbapenemase-Producing Gram-Negative Bacteria and Associated Factors Among Patients Suspected of Community and Hospital-Acquired Urinary Tract Infections at Ayder Comprehensive Specialized Hospital, Tigrai, Ethiopia. Infection and Drug Resistance 16, pages 4025-4037.
Read now
Read now
Articles from other publishers (64)
Koichiro Wada, Ichiro Tsuboi, Satoshi Takahashi, Mitsuru Yasuda, Jun Miyazaki, Kanao Kobayashi, Masahiro Matsumoto, Hiroshi Hayami, Shingo Yamamoto, Hiroshi Kiyota, Junko Sato, Tetsuya Matsumoto, Naoki Hasegawa, Intetsu Kobayashi, Naoya Masumori, Takahiro Kimura, Hiroki Yamada, Kazumasa Matsumoto, Kiyohito Ishikawa, Kiyohide Fujimoto, Katsumi Shigemura, Takuya Sadahira, Kenji Ito, Teruhiko Yokoyama, Masanobu Izumitani, Toru Sumii, Takahide Hosobe, Kazunobu Hikosaka, Motoshi Kawahara, Takashi Sato, Shin Ito, Naruyasu Masue, Takahiko Sakurai, Koji Kokura, Hitoshi Kadena, Takamitsu Morikawa, Yuzuru Minamidate, Mutsumasa Yoh, Jiro Hashimoto, Takahiro Maruyama, Masaru Yoshioka, Kenji Takashima, Shuichi Kawai, Shohei Nishi, Tetsuro Matsumoto, Hideo Hirayama, Hiroshi Okusa, Satoshi Uno, Yoji Inoue, Yuichiro Kurimura, Takeshi Shirane, Eiichiro Takaoka, Takanori Tojo, Soichi Arakawa, Ryoichi Hamasuna, Atsushi Tomioka, Kiyotaka Iihara, Satoshi Ishitoya, Hiroshi Maeda & Michikazu Terado. (2024) Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus. Journal of Infection and Chemotherapy 30:4, pages 277-285.
Crossref
Crossref
Meng Zhao, Shuang Qi, Yinuo Sun & Xue Zheng. (2024) Comparison of polymerase chain reaction and next-generation sequencing with conventional urine culture for the diagnosis of urinary tract infections: A meta-analysis. Open Medicine 19:1.
Crossref
Crossref
Lucas Mainardo Rodrigues Bezerra, Carolina Maria Helene, Ana Beatriz De Moraes Souza Nunes, Elton Pessoa dos Santos, Lana Régia Matias Soares, Bernardo de Oliveira Lima Junior, Graziele Vidal Rezende & Renata Lima Lages Furtado. (2024) AVANÇOS NA TERAPIA FARMACOLÓGICA PARA INFECÇÕES DO TRATO URINÁRIO: UMA REVISÃO BIBLIOGRÁFICA DE LITERATURA. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 5:3, pages e534995.
Crossref
Crossref
Jordan E. Jenrette, Kyle Coronato, Matthew A. Miller, Kyle C. Molina, Alexander Quinones & Gabrielle Jacknin. (2024) Prospective evaluation of single‐dose aminoglycosides for treatment of complicated cystitis in the emergency department. Academic Emergency Medicine.
Crossref
Crossref
Shrutika R. Kumbhar, Aishwarya Babu & Meera S. Modak. (2024) Fosfomycin Susceptibility among Extended-spectrum βeta Lactamase (Esbl)-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Uti in a Tertiary Care Center in Western India. Medical Journal of Dr. D.Y. Patil Vidyapeeth 17:2, pages 328-331.
Crossref
Crossref
Keith S. Kaye, Vikas Gupta, Aruni Mulgirigama, Ashish V. Joshi, Gang Ye, Nicole E. Scangarella-Oman, Kalvin Yu & Fanny S. Mitrani-Gold. (2024) Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019. Antimicrobial Resistance & Infection Control 13:1.
Crossref
Crossref
Syed Yousaf Kazmi, Kauser Fathima, Nazia Khan, Syeda Nazia Kulsum & Ali Faraz. (2024) Sensitivity Profile of Fosfomycin, Nitrofurantoin, and Co-trimoxazole Against Uropathogens Isolated From UTI Cases in a Secondary Care Center, KSA. Cureus.
Crossref
Crossref
Sidrah Hafeez, Rehan Zafar Paracha & Fazal Adnan. (2024) Designing of fragment based inhibitors with improved activity against E. coli AmpC β-lactamase compared to the conventional antibiotics. Saudi Journal of Biological Sciences 31:1, pages 103884.
Crossref
Crossref
Charles E. Deutch. 2024. Ureases. Ureases
297
340
.
Manga J.A. Mbarga, Razan Marouf, Irina V. Podoprigora, Kitio L.D. Anyutoulou, Yuri V. Chapurin & Irina N. Sharova. (2023) Long exposure impact of antibiotics subinhibitory doses and silver nanoparticles on uropathogenic bacteria. RUDN Journal of Medicine 27:3, pages 391-402.
Crossref
Crossref
Varsha Gupta, Paola Mastromarino & Ritu Garg. (2023) Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases.
Crossref
Crossref
Alassane Halawen Mohamed, René Dembélé, Alio Mahamadou Fody, Alix Bénédicte Kagambèga, Hiliassa Coulibaly, Frédéric François Bado, Chaibou Salaou, Laouali Boubou, Alkassoum Ibrahim, Eric Adehossi Omar & Nicolas Barro. (2023) Efficacy of Fosfomycin against Extended Spectrum Beta-Lactamase-Producing Escherichia coli Isolated from Patient Urinary Cultures in the General Reference Hospital of Niamey, Niger. Uro 3:4, pages 262-270.
Crossref
Crossref
Magdalena Zdzieblo, Anna Biernasiuk, Pawel Helon & Anna Malm. (2023)
Fosfomycin activity
in vitro
against
Escherichia coli
strains isolated from urine specimens
. Current Issues in Pharmacy and Medical Sciences 36:4, pages 217-220.
Crossref
Crossref
Tommaso Cai, Paolo Verze, Davide Arcaniolo, Savio Domenico Pandolfo, Francesco Smarrazzo, Celeste Manfredi, Carlo Tascini, Patrizio Caciagli, Massimiliano Lanzafame, Marco De Sio, Florian Wagenlehner, Truls E. Bjerklund Johansen & Alessandro Palmieri. (2023) Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol. International Journal of Antimicrobial Agents 62:5, pages 106974.
Crossref
Crossref
Giovanni Palleschi. 2023. Cystitis - Updates and Challenges. Cystitis - Updates and Challenges.
Elisa Scala, Gaby van Galen, Elin M. Skärlina & Inge Durie. (2023) Do post‐surgical multiresistant urinary infections occur in horses? Case of unilateral pyelonephritis caused by extended‐spectrum beta‐lactamase‐producing bacteria as a complication of cystotomy. Veterinary Medicine and Science 9:5, pages 2042-2052.
Crossref
Crossref
Helen H. Sun, Michael Callegari, Eric Zhou, Stephen Rhodes, Aaron Brant, Erin Jesse, Megan Prunty, Jonathan E. Shoag, Kyle Scarberry, Kirtishri Mishra & Shubham Gupta. (2023) Trends over 20 years of antimicrobial prophylaxis for artificial urinary sphincter surgery. Neurourology and Urodynamics 42:6, pages 1421-1430.
Crossref
Crossref
Hanan O. Alshammari, Ali Somily, Malak Yahia Qattan, Roua A. Alsubki & Ihab M. Moussa. (2023) Susceptibility pattern of multi-drug resistance Pseudomonas aeruginosa isolates from tertiary care hospital in Riyadh, KSA. Journal of King Saud University - Science 35:5, pages 102702.
Crossref
Crossref
Yang Zhou, Zuying Zhou, Lin Zheng, Zipeng Gong, Yueting Li, Yang Jin, Yong Huang & Mingyan Chi. (2023) Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options. International Journal of Molecular Sciences 24:13, pages 10537.
Crossref
Crossref
Grace Morales, Benjamin Abelson, Seth Reasoner, Jordan Miller, Ashlee M. Earl, Maria Hadjifrangiskou & Jonathan Schmitz. (2023) The Role of Mobile Genetic Elements in Virulence Factor Carriage from Symptomatic and Asymptomatic Cases of Escherichia coli Bacteriuria. Microbiology Spectrum 11:3.
Crossref
Crossref
Anjali Vijeata, Ganga Ram Chaudhary, Aman Bhalla & Savita Chaudhary. (2023) 3-Methoxyazetidin-2-one Functionalized CuO–CB Microfibrils: A Drug Formulation with Controlled Release and Enhanced Synergistic Antibacterial Activities. ACS Applied Bio Materials 6:5, pages 1849-1862.
Crossref
Crossref
Saleh Afsharikhah, Reza Ghanbarpour, Parvin Mohseni, Nasrin Adib, Mahboube Bagheri & Maziar Jajarmi. (2023) High prevalence of β-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran. BMC Microbiology 23:1.
Crossref
Crossref
Giuseppe Mancuso, Angelina Midiri, Elisabetta Gerace, Maria Marra, Sebastiana Zummo & Carmelo Biondo. (2023) Urinary Tract Infections: The Current Scenario and Future Prospects. Pathogens 12:4, pages 623.
Crossref
Crossref
S. J. Ryan Arends, Deborah Butler, Nicole Scangarella-Oman, Mariana Castanheira & Rodrigo E. Mendes. (2023) Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020). Antimicrobial Agents and Chemotherapy 67:4.
Crossref
Crossref
Erastus Hanganeni Haindongo, Diana Ndakolo, Marius Hedimbi, Olli Vainio, Antti Hakanen & Jaana Vuopio. (2023) Antimicrobial resistance prevalence of Escherichia coli and Staphylococcus aureus amongst bacteremic patients in Africa: a systematic review. Journal of Global Antimicrobial Resistance 32, pages 35-43.
Crossref
Crossref
Ionela-Larisa Miftode, Daniela Leca, Radu-Stefan Miftode, Florin Roşu, Claudia Plesca, Isabela Loghin, Amalia Stefana Timpau, Ivona Mitu, Irina Mititiuc, Olivia Dorneanu & Egidia Miftode. (2023) The Clash of the Titans: COVID-19, Carbapenem-Resistant Enterobacterales, and First mcr-1-Mediated Colistin Resistance in Humans in Romania. Antibiotics 12:2, pages 324.
Crossref
Crossref
Yousry A. Ammar, Jehan A. Micky, Dina S. Aboul‐Magd, Sondos M. A. Abd El‐Hafez, Sadia A. Hessein, Abeer M. Ali & Ahmed Ragab. (2022)
Development and radiosterilization of new hydrazono‐quinoline hybrids as
DNA
gyrase and topoisomerase
IV
inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study
. Chemical Biology & Drug Design 101:2, pages 245-270.
Crossref
Crossref
Timothy H.S. Cho, Kat Pick & Tracy L. Raivio. (2023) Bacterial envelope stress responses: Essential adaptors and attractive targets. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1870:2, pages 119387.
Crossref
Crossref
Justyna E. Gołębiewska, Beata Krawczyk, Magdalena Wysocka, Aleksandra Dudziak & Alicja Dębska-Ślizień. (2023) Asymptomatic Bacteriuria in Kidney Transplant Recipients—A Narrative Review. Medicina 59:2, pages 198.
Crossref
Crossref
Giuseppe Valerio De Gaetano, Germana Lentini, Agata Famà, Francesco Coppolino & Concetta Beninati. (2023) In Vivo Role of Two-Component Regulatory Systems in Models of Urinary Tract Infections. Pathogens 12:1, pages 119.
Crossref
Crossref
Rajesh Chavan, Bhushan NaphadeBhalchandra WaykarSachin Bhagwat. (2023)
Investigations on
In Vivo
Pharmacokinetic/Pharmacodynamic Determinants of Fosfomycin in Murine Thigh and Kidney Infection Models
. Microbial Drug Resistance 29:1, pages 18-27.
Crossref
Crossref
Mikaela M. Walker, Jason A. Roberts, Benjamin A. Rogers, Patrick N. A. Harris & Fekade B. Sime. (2022) Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review. Antibiotics 11:12, pages 1821.
Crossref
Crossref
Mbarga M. J. Arsene, Podoprigora I. Viktorovna, Goriainov V. Sergei, Fadi Hajjar, Yashina N. Vyacheslavovna, Zhigunova A. Vladimirovna, Vasilyeva E. Aleksandrovna, Senyagin A. Nikolayevich & Nadezhda Sachivkina. (2022) Phytochemical Analysis, Antibacterial and Antibiofilm Activities of Aloe vera Aqueous Extract against Selected Resistant Gram-Negative Bacteria Involved in Urinary Tract Infections. Fermentation 8:11, pages 626.
Crossref
Crossref
Patricia Ortega, Esther Benito & Félix Berrocal. (2022) Clinical Experience with a Medical Device Containing Xyloglucan, Hibiscus, and Propolis for the Control of Acute Uncomplicated Urinary Tract Infection-like Symptoms. Uro 2:4, pages 245-253.
Crossref
Crossref
Gernot Bonkat, Tommaso Cai, Carlotta Galeone, Bela Koves & Franck Bruyere. (2022) Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report. European Urology Open Science 44, pages 37-45.
Crossref
Crossref
Helena Owusu, Pruthu Thekkur, Jacklyne Ashubwe-Jalemba, George Kwesi Hedidor, Oksana Corquaye, Asiwome Aggor, Allen Steele-Dadzie & Daniel Ankrah. (2022) Compliance to Guidelines in Prescribing Empirical Antibiotics for Individuals with Uncomplicated Urinary Tract Infection in a Primary Health Facility of Ghana, 2019–2021. International Journal of Environmental Research and Public Health 19:19, pages 12413.
Crossref
Crossref
Mays B. Jalil & Mohammed Younus Naji Al Atbee. (2022)
The prevalence of multiple drug resistance
Escherichia coli
and
Klebsiella pneumoniae
isolated from patients with urinary tract infections
. Journal of Clinical Laboratory Analysis 36:9.
Crossref
Crossref
Ali Auzin, Menoeska Spits, Evelina Tacconelli, José Rodríguez-Baño, Marlies Hulscher, Eddy Adang, Andreas Voss & Heiman Wertheim. (2022) What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review. Clinical Microbiology and Infection 28:7, pages 928-935.
Crossref
Crossref
Luis Enrique Cabrera-Rodríguez, Ana Ibis Miralles-Suarez, Rosabel Ones-Roque, Yulian Torres-Herrera & Magela Pantaleón-Hernández. (2022) Prevalencia de aislamientos de Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en pacientes cubanos ambulatorios con infección del tracto urinario. Revista de la Facultad de Medicina 71:2, pages e99767.
Crossref
Crossref
Byeonghak Kwak, Jungmi Hong, Hye Gyung Bae, Yoon Soo Park, Mi Kyeong Lee, Kyungwon Lee & Kyoung Ryul Lee. (2022) Microorganisms Isolated from Urine Cultures and Their Antimicrobial Susceptibility Patterns at a Commercial Laboratory during 2018-2020. Korean Journal of Healthcare-Associated Infection Control and Prevention 27:1, pages 51-58.
Crossref
Crossref
Yue-Ying Huang, Xiao-Yu Zhang, Ping Zhu & Ling Ji. (2022) Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applications. World Journal of Clinical Cases 10:18, pages 5934-5945.
Crossref
Crossref
Lewis F. Neville, Itamar Shalit, Peter A. Warn & Jacob T. Rendell. (2022)
Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant
Escherichia coli
burden in a murine complicated urinary tract infection model
. Journal of Antimicrobial Chemotherapy 77:6, pages 1706-1709.
Crossref
Crossref
Shang-Jyun Lin, Po-Hsuan Chao, Ho-Wen Cheng, Juen-Kai Wang, Yuh-Lin Wang, Yin-Yi Han & Nien-Tsu Huang. (2022) An antibiotic concentration gradient microfluidic device integrating surface-enhanced Raman spectroscopy for multiplex antimicrobial susceptibility testing. Lab on a Chip 22:9, pages 1805-1814.
Crossref
Crossref
E. V. Kulchavenya, S. Yu. Shevchenko & D. P. Kholtobin. (2022) Recurrent cystitis in women: principles of rational therapy. Meditsinskiy sovet = Medical Council:5, pages 128-134.
Crossref
Crossref
Hae Do Jung, Kang Su Cho, Young Joon Moon, Doo Yong Chung, Dong Hyuk Kang & Joo Yong Lee. (2022) Antibiotic prophylaxis for percutaneous nephrolithotomy: An updated systematic review and meta-analysis. PLOS ONE 17:4, pages e0267233.
Crossref
Crossref
Ravleen Kaur, Pooja Rani, Atanas G. Atanasov, Qushmua Alzahrani, Reena Gupta, Bhupinder Kapoor, Monica Gulati & Pooja Chawla. (2022) Discovery and Development of Antibacterial Agents: Fortuitous and Designed. Mini-Reviews in Medicinal Chemistry 22:7, pages 984-1029.
Crossref
Crossref
George G. Zhanel, Marianna Pozdirca, Alyssa R. Golden, Courtney K. Lawrence, Sheryl Zelenitsky, Liam Berry, Frank Schweizer, Denice Bay, Heather Adam, Michael A. Zhanel, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Kurt Naber, Joseph P. LynchIIIIII & James A. Karlowsky. (2022) Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Drugs 82:5, pages 533-557.
Crossref
Crossref
Florian Wagenlehner, Lindsay Nicolle, Riccardo Bartoletti, Ana C. Gales, Larissa Grigoryan, Haihui Huang, Thomas Hooton, Gustavo Lopardo, Kurt Naber, Aruna Poojary, Ann Stapleton, David A. Talan, José Tirán Saucedo, Mark H. Wilcox, Shingo Yamamoto, Stephen S. Yang & Seung-Ju Lee. (2022) A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance. Journal of Global Antimicrobial Resistance 28, pages 18-29.
Crossref
Crossref
Tribeni Goswami, MathewSamuel Krishnamurthy & SangeethaMerrin Varghese. (2022) A study on the pathogenic microbes and antibiotic-sensitivity patterns in urinary tract infection among diabetes patients at a tertiary care hospital in Central Kerala. Journal of Current Research in Scientific Medicine 8:2, pages 140.
Crossref
Crossref
Antonio MilanoAdela SulejmaniJari Intra, Maria Roberta SalaValerio LeoniDavide Carcione. (2022)
Antimicrobial Resistance Trends of
Escherichia coli
Isolates from Outpatient and Inpatient Urinary Infections over a 20-Year Period
. Microbial Drug Resistance 28:1, pages 63-72.
Crossref
Crossref
Pengfei She, Shijia Li, Yaqian Liu, Lanlan Xu, Linying Zhou, Xianghai Zeng, Yimin Li, Shasha Liu, Zehao Li, Zubiar Hussain & Yong Wu. (2021) Repurposing Sitafloxacin, Prulifloxacin, Tosufloxacin, and Sisomicin as Antimicrobials Against Biofilm and Persister Cells of Pseudomonas aeruginosa. Current Microbiology 79:1.
Crossref
Crossref
Trusha Nana, Shastra Bhoora & Vindana Chibabhai. (2021) Trends in the epidemiology of urinary tract infections in pregnancy at a tertiary hospital in Johannesburg: Are contemporary treatment recommendations appropriate?. Southern African Journal of Infectious Diseases 36:1.
Crossref
Crossref
Béla Kocsis, Dániel Gulyás & Dóra Szabó. (2021) Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline. Antibiotics 10:12, pages 1506.
Crossref
Crossref
S. S. Andreev, T. K. Isaev, R. N. Trushkin & D. F. Kantimerov. (2021) Complicated urinary tract infection in a patient with severe COVID-19. Ural Medical Journal 20:5, pages 68-74.
Crossref
Crossref
Ivana Kerkez, Paul M. Tulkens, Tanel Tenson, Françoise Van Bambeke & Marta Putrinš. (2021)
Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an
In Vitro
Model of Intracellular Infection
. Antimicrobial Agents and Chemotherapy 65:12.
Crossref
Crossref
Katja Becker, Sha Cao, Anna Nilsson, Maria Erlandsson, Sven-Kevin Hotop, Janis Kuka, Jon Hansen, Klara Haldimann, Solveiga Grinberga, Talia Berruga-Fernández, Douglas L. Huseby, Reza Shariatgorji, Evelina Lindmark, Björn Platzack, Erik C. Böttger, David Crich, Lena E. Friberg, Carina Vingsbo Lundberg, Diarmaid Hughes, Mark Brönstrup, Per E. Andrén, Edgars Liepinsh & Sven N. Hobbie. (2021) Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis. EBioMedicine 73, pages 103652.
Crossref
Crossref
Kaushik Kumar Bharadwaj, Bijuli Rabha, Bhabesh Kumar Choudhury, Rosina Rosalin, Tanmay Sarkar, Debabrat Baishya, Naorem Bidyaleima Chanu, Yengkhom Disco Singh, Manasa Kumar Panda & Siddhartha Pati. (2021) Current strategies in inhibiting biofilm formation for combating urinary tract infections: Special focus on peptides, nano-particles and phytochemicals. Biocatalysis and Agricultural Biotechnology 38, pages 102209.
Crossref
Crossref
V. L. Tyutyunnik, N. E. Kan & L. V. Khachatryan. (2021) General principles of uncomplicated cystitis therapy during pregnancy. Meditsinskiy sovet = Medical Council:13, pages 121-126.
Crossref
Crossref
Thomas P Lodise, Anne Santerre Henriksen, Thomas Hadley & Nimish Patel. (2021) US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales. Open Forum Infectious Diseases 8:10.
Crossref
Crossref
Jaeik Song, Min-Suk Kook, Byung-Hoon Kim, Young-IL Jeong & Kyung-Jin Oh. (2021) Ciprofloxacin-Releasing ROS-Sensitive Nanoparticles Composed of Poly(Ethylene Glycol)/Poly(D,L-lactide-co-glycolide) for Antibacterial Treatment. Materials 14:15, pages 4125.
Crossref
Crossref
Nicole Jackson, Clarissa A. Borges, Nicole J. Tarlton, Angel Resendez, Aubrianne K. Milton, Tara R. de Boer, Cheyenne R. Butcher, Niren Murthy & Lee W. Riley. (2021) A rapid, antibiotic susceptibility test for multidrug-resistant, Gram-negative bacterial uropathogens using the biochemical assay, DETECT. Journal of Microbiological Methods 182, pages 106160.
Crossref
Crossref
A. S. Leuin, F. Hartmann & K. Viviano. (2020) Administration of nitrofurantoin in dogs with lower urinary tract infections: 14 cases (2013‐2019). Journal of Small Animal Practice 62:1, pages 42-48.
Crossref
Crossref
Giulio Petronio Petronio, Marco Alfio Cutuli, Irene Magnifico, Noemi Venditti, Laura Pietrangelo, Franca Vergalito, Antonella Pane, Giovanni Scapagnini & Roberto Di Marco. (2020) In Vitro and In Vivo Biological Activity of Berberine Chloride against Uropathogenic E. coli Strains Using Galleria mellonella as a Host Model. Molecules 25:21, pages 5010.
Crossref
Crossref
Lenka Rodriguez, Roman Fišera, Barbora Gaálová, Kamila Koči, Helena Bujdáková, Mária Mečiarová, Renáta Górová, Helena Jurdáková & Radovan Šebesta. (2020) Synthesis of Chiral 3,4‐Disubstituted Pyrrolidines with Antibacterial Properties. European Journal of Organic Chemistry 2020:17, pages 2565-2575.
Crossref
Crossref